An Implantable Microstimulator for the Chronic Treatment of Urinary Urgency-Frequency Syndrome
Completed · Phase 3
Conditions studied: Overactive Bladder
In brief
The goal of this study is to investigate the safety and effectiveness of a new implanted device designed to treat Urinary Urgency-Frequency Syndrome.
Key facts
- Study ID
- NCT00131573
- Run by
- Boston Scientific Corporation
- People needed
- 118
- Starts
- 2004-05-01
- Expected to finish
- 2012-12-01
- Last updated by the study team
- 2013-11-19
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Arizona Health Sciences Center — Tucson, Arizona, United States
- The Department of Urology, Stanford University Medical Center — Stanford, California, United States
- Milestone Medical Research — Englewood, Colorado, United States
- Walter Reed Army Medical Center — Washington D.C., District of Columbia, United States
- Overland Park Regional Medical Center — Overland Park, Kansas, United States
- William Beaumont Hospital — Royal Oak, Michigan, United States
- Cornerstone Medical Specialty Center — Woodbury, Minnesota, United States
- New York University — New York, New York, United States
- Cleveland Clinic Foundation — Cleveland, Ohio, United States
- The Pelvic and Sexual Health Institute — Philadelphia, Pennsylvania, United States
- Dallas Center for Pelvic Medicine — Dallas, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.